Inventor · disambiguated record
John Wheeler
Also filed as: WHEELER JOHN · Wheeler John Scott
26 granted patents·11 pending applications·137 citations·filing 2009–2024
95Inventor score
Files withJANSSEN BIOTECH INC15CENTURY THERAPEUTICS INC9JANSSEN PHARMACEUTICA NV3ALMAGRO JUAN CARLOS1BD KIESTRA BV1
Top patents by PatentIndex Score
37 records- 0196US9102737B2Human anti-CD27 antibodies, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted Aug 11, 2015·36 cites·16 claims
- 0292US9850310B2CD123 binding agents and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Dec 26, 2017·23 cites·20 claims
- 0392US9090694B2ST2L antibody antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Jul 28, 2015·19 cites·4 claims
- 0490US9683046B2Nucleic acid molecules encoding anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2015·Granted Jun 20, 2017·7 cites·20 claims
- 0590US9212227B2ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditionsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 15, 2015·13 cites·15 claims
- 0689US8394378B2Antibodies binding human collagen IIKEHOE JOHN·Filed 2011·Granted Mar 12, 2013·18 cites·5 claims
- 0785US2024141055A1Human Anti-CD27 AntibodiesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0884US11414484B2Anti-CCL17 antibodiesJANSSEN BIOTECH INC·Filed 2020·Granted Aug 16, 2022·1 cites·12 claims
- 0984US10301392B2Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2017·Granted May 28, 2019·3 cites·5 claims
- 1084US9951137B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2015·Granted Apr 24, 2018·4 cites·6 claims
- 1181US2024248111A1Diagnostic test device with internal cylinders and plungerBECTON DICKINSON CO·Filed 2024·Application pending·0 cites
- 1279US9944697B2Anti-CCL17 antibodiesJANSSEN BIOTECH INC·Filed 2014·Granted Apr 17, 2018·1 cites·8 claims
- 1378US8785605B2Humanized IL-25 antibodiesALMAGRO JUAN CARLOS·Filed 2011·Granted Jul 22, 2014·5 cites·13 claims
- 1476US10829549B2Anti-CCL17 antibodiesJANNSEN BIOTECH INC·Filed 2017·Granted Nov 10, 2020·1 cites·7 claims
- 1576US10633435B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 28, 2020·1 cites·19 claims
- 1676US10450377B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2018·Granted Oct 22, 2019·1 cites·18 claims
- 1775US8906649B2Antibodies binding human collagen IIJANSSEN BIOTECH INC·Filed 2013·Granted Dec 9, 2014·2 cites·5 claims
- 1875US2022348647A1Anti-ccl17 antibodiesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1973US11732050B2Neutralizing human anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2020·Granted Aug 22, 2023·0 cites·7 claims
- 2072US2024216429A1Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2169US10689453B2Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodiesJANSSEN BIOTECH INC·Filed 2019·Granted Jun 23, 2020·0 cites·5 claims
- 2268US11883432B2Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·13 claims
- 2368US2025059286A1Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2467US12269888B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·4 claims
- 2567US9062305B2Generation of human de novo pIX phage display librariesTSUI PING·Filed 2009·Granted Jun 23, 2015·2 cites·1 claims
- 2663US2025360210A1Immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2761US12234280B2Anti-PHF-tau antibodies and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 25, 2025·0 cites·10 claims
- 2858US11661459B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2021·Granted May 30, 2023·0 cites·11 claims
- 2956US2025064934A1Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereofCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3056US2023381317A1Methods for controlled activation and/or expansion of genetically engineered cells using polyethylene glycol (peg) receptorsCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3154US9248194B2Affinity peptides toward infliximabJANSSEN BIOTECH INC·Filed 2014·Granted Feb 2, 2016·0 cites·8 claims
- 3253US2022331361A1Gene transfer vectors and methods of engineering cellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3350US2025127442A1Blood collection systemBD KIESTRA BV·Filed 2022·Application pending·0 cites
- 3447US10207856B2Liquid release deviceSUSTAINED RELEASED TECH INC·Filed 2017·Granted Feb 19, 2019·0 cites·1 claims
- 3547US8822423B2Affinity peptides toward infliximabRYAN DAPHNE ANN SALICK·Filed 2012·Granted Sep 2, 2014·0 cites·9 claims
- 3635US2018250525A1Methods and devices for displacing tissues during brachytherapyMEDICAL TOOL AND TECH LLC·Filed 2018·Application pending·0 cites
- 3732US9808649B2Immobilization system to support an in vivo medical deviceMEDICAL TOOL & TECH LLC·Filed 2017·Granted Nov 7, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when John Wheeler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →